Multinational drug corporations withstand against expensive medication controls.

Foreign multinational drug corporations in Korea strongly resisted against the NHIC's insurance reimbursement controls over the medication of expensive drugs mostly supplied by their products, claiming it as a short-sighted measure that not only infringes physician's prescription rights but also puts aside the medical economic fundamentals.

The Health Insurance Revew Agency (HIRA) restricted...